Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 1.8x - 2.0x | 1.9x |
| Selected Fwd Ps Multiple | 1.7x - 1.9x | 1.8x |
| Fair Value | ₩276.95 - ₩306.10 | ₩291.53 |
| Upside | 14.0% - 26.0% | 20.0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| IL Science Co., Ltd. | - | KOSDAQ:A307180 |
| Atum Co.,Ltd | - | KOSDAQ:A355690 |
| CNPLUS Co., Ltd. | - | KOSDAQ:A115530 |
| SDN Company., Ltd. | - | KOSDAQ:A099220 |
| Dasan Solueta Co.,Ltd. | - | KOSDAQ:A154040 |
| TS Nexgen Co., Ltd. | - | KOSDAQ:A043220 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| A307180 | A355690 | A115530 | A099220 | A154040 | A043220 | |||
| KOSDAQ:A307180 | KOSDAQ:A355690 | KOSDAQ:A115530 | KOSDAQ:A099220 | KOSDAQ:A154040 | KOSDAQ:A043220 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | NM- | 22.3% | 8.3% | 4.4% | -6.9% | -7.7% | ||
| 3Y CAGR | 30.6% | -11.6% | 18.0% | -1.8% | 1.7% | 5.3% | ||
| Latest Twelve Months | 113.7% | -19.5% | -25.9% | 11.5% | 3.3% | -23.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -15.8% | -21.2% | -7.4% | -3.3% | -0.7% | -17.9% | ||
| Prior Fiscal Year | 3.9% | -16.5% | 4.0% | 0.7% | 2.5% | -38.0% | ||
| Latest Fiscal Year | -47.5% | -7.2% | 1.1% | -11.5% | 15.7% | 0.1% | ||
| Latest Twelve Months | -10.4% | -7.2% | -2.6% | -24.4% | 16.4% | -32.5% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 15.6x | -62.9x | 22.0x | -24.0x | 2.1x | -17.5x | ||
| Price / LTM Sales | 0.9x | 0.9x | 0.7x | 0.6x | 0.1x | 1.7x | ||
| LTM P/E Ratio | 173.5x | -13.0x | -25.6x | -2.0x | 0.6x | -5.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.1x | 0.7x | 0.9x | |||||
| Historical LTM P/S Ratio | 2.3x | 4.1x | 10.0x | |||||
| Selected Price / Sales Multiple | 1.8x | 1.9x | 2.0x | |||||
| (x) LTM Sales | 22,837 | 22,837 | 22,837 | |||||
| (=) Equity Value | 41,388 | 43,566 | 45,744 | |||||
| (/) Shares Outstanding | 159.2 | 159.2 | 159.2 | |||||
| Implied Value Range | 259.93 | 273.61 | 287.30 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 259.93 | 273.61 | 287.30 | 243.00 | ||||
| Upside / (Downside) | 7.0% | 12.6% | 18.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A307180 | A355690 | A115530 | A099220 | A154040 | A043220 | |
| Value of Common Equity | 74,908 | 35,997 | 22,020 | 54,226 | 17,519 | 38,691 | |
| (/) Shares Outstanding | 27.0 | 5.4 | 68.0 | 54.2 | 18.0 | 159.2 | |
| Implied Stock Price | 2,770.00 | 6,660.00 | 324.00 | 1,001.00 | 976.00 | 243.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2,770.00 | 6,660.00 | 324.00 | 1,001.00 | 976.00 | 243.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |